The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

When your blood sugar levels fall within the recommended ranges, it’s a sign your diabetes treatment and management plan is working. You and your doctor can determine your exact blood sugar ...

SATURDAY, March 8, 2025 (HealthDay News) -- Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 cause of death in the United ...

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies ...

Up to thirty percent of Lewy body dementia patients develop Lewy body dementia because they have mutations in these genes. And there is a third rare disease called Gaucher disease and again also ...

Gaucher disease (GD) is an inherited disorder caused by recessive mutations in the GBA1 gene that encodes the lysosomal enzyme β-glucocerebrosidase (β-GC). β-GC hydrolyzes glucosylceramide (GluCer) ...

Using a chart of blood sugar levels by age can help you track glucose ... In addition, nearly 27% of people with the disease are over age 65. Low blood sugar is also a concern. Researchers say ...

England’s NHS will routinely fund Sanofi/Genzyme’s Cerdelga (eliglustat) for the rare condition Gaucher disease after a recommendation from NICE. The cost effectiveness body published final ...

Importance: Gaucher disease (GD) is a rare lysosomal storage disorder with limited treatment options for pediatric patients. Oral substrate reduction therapy (SRT) with eliglustat offers a potential ...

New genetic risk score identifies individuals at risk for heart disease who may benefit most from cholesterol-lowering therapies. ScienceDaily . Retrieved March 24, 2025 from www.sciencedaily.com ...